Metraipolis › archive › dc_b2e710aacf2d

Loss of UFL1 confers enzalutamide resistance of prostate tumors by regulating METTL16-mediated m6A modification of EEF1A1 mRNA — Europe PMC PMID:41608626

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41608626
DOI
10.7150/ijbs.124214
License (as archived)
solo-consultazione
Archived
2026-11-07T03:38:11.165Z
SHA-256 of the archived text
7c32f1c0349dcbd33e4f770efe3c48a544f1d578c7bb1b6d6ccb6bffeb9a8fdb
Stable URL of this page
https://metraipolis.com/documento/dc_b2e710aacf2d

How to cite

Loss of UFL1 confers enzalutamide resistance of prostate tumors by regulating METTL16-mediated m6A modification of EEF1A1 mRNA — Europe PMC PMID:41608626 — Europe PMC (en), https://europepmc.org/article/MED/41608626 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b2e710aacf2d (Metraipolis archive dc_b2e710aacf2d, sha256 7c32f1c0349dcbd33e4f770efe3c48a544f1d578c7bb1b6d6ccb6bffeb9a8fdb)
BibTeX
@misc{dcb2e710aacf2d,
  title = {Loss of UFL1 confers enzalutamide resistance of prostate tumors by regulating METTL16-mediated m6A modification of EEF1A1 mRNA — Europe PMC PMID:41608626},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41608626},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b2e710aacf2d; sha256 7c32f1c0349dcbd33e4f770efe3c48a544f1d578c7bb1b6d6ccb6bffeb9a8fdb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41608626. Agents can read the archived copy with the MCP tool read_document.